1. FRI0252 Efficacy of Mycophenolate Mofetil (MMF) versus Oral Cyclophosphamide (CYC) on Skin Thickness in The Scleroderma Lung Study II. (15th July 2016) Authors: Khanna, D.; Tashkin, D.; Furst, D.E.; Tseng, C.-H.; Wilhalme, H.; Roth, M.; Kafaja, S.; Volkmann, E.; Elashoff, R.; Clements, P. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 525 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0267 Mycophenolate Mofetil versus Oral Cyclophosphamide in Scleroderma-Related Interstitial Lung Disease: Scleroderma Lung Study II. (15th July 2016) Authors: Khanna, D.; Roth, M.; Clements, P.; Furst, D.; Tseng, C.-H.; Elashoff, R.; Volkmann, E.; Kafaja, S.; Goldin, J.; Tashkin, D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0274 Predictors of Survival in Patients with Systemic Sclerosis-Related Interstitial Lung Disease Enrolled in The Scleroderma Lung Study II. (15th July 2016) Authors: Volkmann, E.; Tashkin, D.; Fischer, A.; Hoffmann-Vold, A.-M.; Tseng, C.-H.; LeClair, H.; Khanna, D.; Clements, P.; Roth, M.; Elashoff, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 534 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0275 Change in CXCL4 Levels May Predict Treatment Response in Systemic Sclerosis-Related Interstitial Lung Disease (SSC-ILD). (15th July 2016) Authors: Volkmann, E.; Tashkin, D.; Elashoff, R.; Tseng, C.-H.; Khanna, D.; Mayes, M.; Charles, J.; Clements, P.; Roth, M.; Furst, D.; Assassi, S. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0251 Vascular Involvement in Scleroderma; Phenotypic Variability with Different Mechanistic Pathways. (15th July 2016) Authors: Suliman, Y.A.S.; Kafaja, S.; Alemam, M.F.; Valera, I.; Jackson, N.; Alkady, E.; Mosad, E.; Mansour, E.; Fathi, N.; Marsh, E.; Morales, W.; Fitzgerald, J.; Clements, P.; Shapiro, S.; Pimentel, M.; Singh, R.R.; Furst, D.E. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗